{
    "clinical_study": {
        "@rank": "33458", 
        "arm_group": {
            "arm_group_label": "ARPE", 
            "description": "Trapezio-metacarpal prosthesis ARPE"
        }, 
        "brief_summary": {
            "textblock": "Comparison of functional outcome at 3 years after trapezio-metacarpal arthroplasty with\n      trapeziectomy and trapeziectomy with ligament reconstruction and tendon interposition."
        }, 
        "brief_title": "ARPE Prosthesis Study", 
        "completion_date": {
            "#text": "April 2020", 
            "@type": "Anticipated"
        }, 
        "condition": "Arthritis", 
        "condition_browse": {
            "mesh_term": "Arthritis"
        }, 
        "detailed_description": {
            "textblock": "The primary objective is to compare functional outcome at 3 years after trapezio-metarcarpal\n      arthroplasty with trapeziectomy and trapeziectomy with ligament reconstruction and tendon\n      interposition. Literature values obtained by a recently published meta analysis1 will be\n      used.\n\n      Secondary objectives are:\n\n        -  to compare functional outcome at 1 and at 5 years after trapezio-metarcarpal\n           arthroplasty with trapeziectomy and trapeziectomy with ligament reconstruction and\n           tendon interposition\n\n        -  to determine pre- and postop HR QOL\n\n        -  Incidence of RLL at each follow up time point. Literature values from the same meta\n           analysis1 will be used."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  patients with trapezio-metacarpal arthritis Eaton Stage of trapezio-metacarpal\n             arthritis : Stage II - IV\n\n          -  willing to return for follow up evaluation.\n\n        Exclusion Criteria:\n\n          -  local or systemic infections\n\n          -  severe muscular, neurological or vascular deficiencies of the extremity involved\n\n          -  bone destruction or poor bone to affect implant stability\n\n          -  allergy to any of the components of the implant"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "patients with trapezio-metacarpal arthritis Eaton Stage of trapezio-metacarpal arthritis :\n        Stage II - IV"
            }
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 19, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01904019", 
            "org_study_id": "ORTHO.CR.E16"
        }, 
        "intervention": {
            "arm_group_label": "ARPE", 
            "intervention_name": "ARPE", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "arthroplasty", 
            "trapezio-metacarpial"
        ], 
        "lastchanged_date": "March 25, 2014", 
        "location": {
            "contact": {
                "email": "frederik.verstreken@azmonica.be", 
                "last_name": "Frederik Verstreken, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Deurne", 
                    "country": "Belgium", 
                    "zip": "2100"
                }, 
                "name": "SPM Deurne"
            }, 
            "investigator": {
                "last_name": "Frederik Verstreken, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Belgium"
        }, 
        "number_of_groups": "1", 
        "official_title": "Trapezio-metacarpal Arthroplasty: Comparison of ARPE Prosthesis With the Literature", 
        "overall_contact": {
            "email": "frederik.verstreken@azmonica.be", 
            "last_name": "Frederik Verstreken, Dr"
        }, 
        "overall_official": {
            "affiliation": "SPM Deurne", 
            "last_name": "Frederik VERSTREKEN, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "April 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Functional outcome: hand function, strength (grip, key pinch & tip pinch)", 
            "measure": "Functional outcome", 
            "safety_issue": "No", 
            "time_frame": "3 years follow-up"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01904019"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "- Subjective outcomes: postoperative pain data", 
                "measure": "pain", 
                "safety_issue": "No", 
                "time_frame": "5 years follow-up"
            }, 
            {
                "description": "- functional outcomes at 1 and 5 years follow up after trapezio-metacarpal arthroplasty / trapeziectomy and trapeziectomy with LRTI.", 
                "measure": "hand function", 
                "safety_issue": "No", 
                "time_frame": "5 years follow-up"
            }, 
            {
                "description": "- ROM (palmar and radial abduction)at 1, 3 & 5 years follow-up", 
                "measure": "Motion", 
                "safety_issue": "No", 
                "time_frame": "5 years follow-up"
            }, 
            {
                "description": "- pre- and post Health Related QOL at 1, 3 & 5 years follow-up", 
                "measure": "Quality of life", 
                "safety_issue": "No", 
                "time_frame": "5 years follow-up"
            }, 
            {
                "description": "- Incidence of Radiolucency lines at 1, 3 & 5 years follow-up", 
                "measure": "Radiographic assessment", 
                "safety_issue": "No", 
                "time_frame": "5 years follow-up"
            }, 
            {
                "description": "- frequency of postoperative adverse events", 
                "measure": "adverse event", 
                "safety_issue": "Yes", 
                "time_frame": "as requested"
            }
        ], 
        "source": "Biomet, Inc.", 
        "sponsors": {
            "collaborator": {
                "agency": "Biomet Belgium BVBA", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Biomet, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "March 2014"
    }
}